Johnson & Johnson beats revenue, profit projections for 2Q

Fueled by a 20 percent sales jump in its prescription drugs business, Johnson & Johnson posted a 3 percent increase in second-quarter profit.

Still, the world's biggest maker of health care products trimmed its forecast for 2018.